Eyetube Back Button
Interventional Glaucoma Case Series Image

Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.

A Young Patient With Significant Glaucomatous Damage

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

Nathan Radcliffe, MD, sits down with I. Paul Singh, MD, and Sarah Van Tassel, MD, to discuss the use of the Xen Gel Stent (Allergan) in a 27-year-old medical student on four topical medications with high IOPs and diffuse retinal nerve fiber layer loss. The surgeons examine the advantages and disadvantages of ab interno and ab externo implantation techniques.

Other Videos

Thumbnail for bldqqi

Choosing an Approach Amid Postoperative Concerns

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for kbradw

A Tolerant Drop User With Visually Significant Cataracts

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for fazjndz

A Young Patient With Significant Glaucomatous Damage

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for guosro

Minimizing the Medication Burden With Sustained Drug Delivery

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.

Logos